Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05297396 · ClinicalTrials.gov registry record · NA
Slow Opioid Tapering Pilot Study of Patients Using Chronic Opioid Therapy
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05297396: Completed NA study, sponsored by Mayo Clinic.
NCT05297396 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05297396, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if patients who have been taking a stable dose of opioids for chronic pain would experience any worsening pain, quality of life and functioning, as well as symptoms of depression and anxiety if their opioid medications are gradually and very slowly reduced.
Interventions
- OTHER Slow Tapering of Chronic Opioid Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05297396
The ClinicalTrials.gov registry entry for NCT05297396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Slow Tapering of Chronic Opioid Therapy is the first listed.
NCT05297396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05297396 about?
NCT05297396 is a clinical study titled "Slow Opioid Tapering Pilot Study of Patients Using Chronic Opioid Therapy". The purpose of this study is to find out if patients who have been taking a stable dose of opioids for chronic pain would experience any worsening pain, quality of life and functioning, as well as symptoms of depression and anxiety if their opioid medications are gradually and very slowly reduced.
What is the current status of trial NCT05297396?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-07-01. Estimated completion is 2026-01-31.
What interventions are being tested in trial NCT05297396?
The interventions under investigation include: Slow Tapering of Chronic Opioid Therapy (OTHER).
Who is sponsoring clinical trial NCT05297396?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.